Tranexamic Acid in Dacryocystorhinostomy

• Status: Unknown status
• Trial end date: 2012-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Single dose tranexamic acid (TA) before dacryocystorhinostomy (DCR) operation: a prospective, double blind, placebo controlled study.

The study hypothesis: TA in DCR might reduce the intraoperative and postoperative bleeding in DCR surgery, and might reduce the duration of the surgery.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: HaEmek Medical Center, Israel
• Treatments: Tranexamic Acid

Criteria

Inclusion Criteria:

• obstruction of nasolacrimal pathway

• eligible for DCR surgery

• 18 years of age or older

Exclusion Criteria:

• warfarin treatment

• renal insufficiency

• pregnancy

• mental retardation

• tendency to bleed

• thromboembolic disease

• thrombophilia